Your browser doesn't support javascript.
loading
[Liver cancer treatment with mitochondrial homeostasis].
Song, M F; Ma, L Y; Shen, C; Zhao, Q; Zhao, C Y.
Afiliación
  • Song MF; Department of Infectious Disease, the Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.
  • Ma LY; Department of Infectious Disease, the Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.
  • Shen C; Department of Infectious Disease, the Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.
  • Zhao Q; Quality Management and Control Office, the Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.
  • Zhao CY; Department of Infectious Disease, the Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.
Zhonghua Gan Zang Bing Za Zhi ; 32(3): 257-261, 2024 Mar 20.
Article en Zh | MEDLINE | ID: mdl-38584111
ABSTRACT
Systemic treatment, including molecular targeted therapy, immunotherapy, and chemotherapy, is an important means of achieving long-term survival in patients with intermediate-and advanced-stage liver cancer. However, some patients are insensitive to treatment and even develop drug resistance. Mitochondria are the center of cellular energy metabolism and, at the same time, are the priority targets for systemic therapy. Mitochondrial homeostasis plays an important role in the treatment of liver cancer. The relationship between the two advances is elucidated so as to provide better ideas for the clinical treatment of liver cancer.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Hepáticas / Mitocondrias Límite: Humans Idioma: Zh Revista: Zhonghua Gan Zang Bing Za Zhi Asunto de la revista: GASTROENTEROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Hepáticas / Mitocondrias Límite: Humans Idioma: Zh Revista: Zhonghua Gan Zang Bing Za Zhi Asunto de la revista: GASTROENTEROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China